The increasing incidence of chronic diseases such as kidney problems, diabetes, neurological diseases, and others are driving the global sexual dysfunction treatment market predicts Fortune Business Insights in their new study. The study is titled” Female Sexual Dysfunction Treatment Market Size, Share and Global Trend By Type (Arousal Disorder, Penetration Disorder, Female Orgasmic Disorder), By Therapy (Estrogen Therapy, Androgen Therapy, Others), By Age (25 Years, 25-40 Years, Above 40 Years) and Geography Forecast Till 2026.”. This report focusses on major factors restricting and driving the growth of the female sexual dysfunction treatment market during the forecast period, 2018 to 2026.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/female-sexual-dysfunction-treatment-market-100850
As per the report, the age group of 40 years and above is dominating the current female sexual dysfunction treatment market and anticipated to continue doing so in the coming years. This is attributable to the wide adoption of unhealthy lifestyle resulting in hormonal imbalance, further leading to sexual dysfunction.
Psychological Problems Leading to Sexual Dysfunction in Women
The main reason behind sexual dysfunction is psychological or physical disorders including heart problems and neurological diseases. In addition to this, problems such as hormonal imbalance, diabetes, kidney diseases, liver problem, drug abuse, alcoholism, and others also lead to sexual dysfunction. Psychological problems causing sexual dysfunction include situations such as work-related stress, past trauma, relationship problems, anxiety, and others. All factors mentioned above leads to the prevalence of sexual dysfunction in women and thus boost the global female sexual dysfunction treatment market.
Studies have showed female sexual dysfunction may happen to a woman at any stage of life. Thus, such facts are likely to help the female sexual dysfunction market gain traction in the forecast period.
On the contrary, lack of awareness about sexual problems and their proper diagnostics, especially in the developing nations, may hamper the market growth. This, accompanied by the lack of standardization in treatment facilities and lack of skilled medical professionals may also cause hinder the female sexual dysfunction market growth in the long run.
Some of the Main Key Players Covered in the Female Sexual Dysfunction Treatment Market Report:
- Apricus Biosciences, Inc.
- GlaxoSmithKline, plc.
- Pzer, Inc.
- AMAG Pharmaceuticals
- Merck & Co., Inc.
- Cipla Inc.
Key Segmentation of Female Sexual Dysfunction Treatment Market:
- Arousal Disorder
- Penetration Disorder
- Female Orgasmic Disorder
- Estrogen Therapy
- Androgen Therapy
- 25 Years
- 25-40 Years
- Above 40 Years
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of
- Asia Pacic (Japan, China, India, Australia, Southeast Asia, and Rest of Asia
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (South Africa, GCC, and Rest of the Middle East &
Awareness Programs Supported and Conducted by Government to Help Asia Pacific Market Register Faster Growth
Fortune Business Insights predicts North America and Europe female sexual dysfunction treatment market to exhibit strong growth. This is on account of the lifestyle adopted by its residents and rise in the number of the aging population. Besides this, the adoption of unhealthy lifestyle, alcoholism, and other habits are leading to the prevalence of sexual dysfunction in women. This is likely to remain the same helping both regions continue dominating the market collectively in future.
On the other side, the female sexual dysfunction treatment market in the Asia Pacific is likely to grow at faster rate on account of rising awareness about sexual diseases, and the availability of treatment facilities, especially in developing nation such as China, and India. Additionally, governments are also initiating various awareness programs about female sexual dysfunction and increasing the funds on the betterment of healthcare infrastructure and facilities, and this will help the market in Asia Pacific register faster growth rate in the forecast period.
New Drug Approvals to Bode Well for Market Players
Companies are focussing on major strategies such as new product launches, company collaborations, and merger and acquisitions for gaining the lion’s share in the market. For instance, a new drug application (NDA) of a first-in-class melanocortin-4 receptor called bremelanotide by AMAG Pharmaceuticals was accepted by the Food and Drug Administration (FDA). This drug is meant to treat hypoactive sexual desire disorders (HSDD) among premenopausal women. Such innovations are likely to bode well for the market as well for company portfolio in future.
Some of the companies functioning in the global female sexual dysfunction treatment market are Cipla Inc., Pfizer, Inc., AMAG Pharmaceuticals, Apricus Biosciences, Inc., Merck & Co., Inc., GlaxoSmithKline, plc., and others.
More Trending Topics from Fortune Business Insights:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Related Reports :